Inhibition of motility and invasiveness of renal cell carcinoma induced by short interfering RNA transfection of β1,4GalNAc transferase

FEBS Letters

Volumn 567, Issue 2-3, 2004, Pages 203-208

  Aoki, Hiroshi ^a   Satoh, Makoto ^a   Mitsuzuka, Koji ^a   Ito, Akihiro ^a   Saito, Seiichi ^a   Funato, Tadao ^a   Endoh, Mareyuki ^a   Takahashi, Toshiko ^a   Arai, Yoichi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

1,4GalNAc T, 1,4GalNAc transferase; C M, chloroform methanol; dsiRNA, disordered siRNA; GAPDH, glyceraldehyde 6 phosphate dehydrogenase; GSL, glycosphingolipid; mAb, monoclonal antibody; PCR, polymerase chain reaction; RCC, renal cell carcinoma

Indexed keywords

ANTIGEN; BETA1,4 N ACETYLGALACTOSAMINYLTRANSFERASE; CD9 ANTIGEN; EPITOPE; GANGLIOSIDE; GANGLIOSIDE GM2; GANGLIOSIDE GM3; INTEGRIN; MONOSIALOGANGLIOSIDE; RM2 ANTIGEN; RNA; SMALL INTERFERING RNA; TETRASPANIN; TRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL MOTILITY; CONTROLLED STUDY; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSFECTION; GROWTH RATE; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ANTIGENS; ANTIGENS, CD; CARCINOMA, RENAL CELL; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; G(M2) GANGLIOSIDE; G(M3) GANGLIOSIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; N-ACETYLGALACTOSAMINYLTRANSFERASES; NEOPLASM INVASIVENESS; RNA; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 2942564621     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2004.04.060     Document Type: Article

References (20)

1. Fukushi Y., Ohtani H., Orikasa S. J. Natl. Cancer Inst. 81:1989;352-358
2. Saito S., Orikasa S., Ohyama C., Satoh M., Fukushi Y. Int. J. Cancer. 49:1991;329-334
3. Satoh M., Handa K., Saito S., Tokuyama S., Ito A., Miyao N., Orikasa S., Hakomori S. Cancer Res. 56:1996;1932-1938
4. Ito A., Levery S.B., Saito S., Satoh M., Hakomori S. J. Biol. Chem. 276:2001;16695-16703
5. Saito S., Levery S.B., Salyan M.E.K., Goldberg R.I., Hakomori S. J. Biol. Chem. 269:1994;5644-5652
6. Ito A., Handa K., Withers D.A., Satoh M., Hakomori S. FEBS Lett. 498:2001;116-120
7. Nagata Y., Yamashiro S., Yodoi J., Lloyd K.O., Shiku H., Furukawa K. J. Biol. Chem. 267:1992;12082-12089
8. Elbashir S.M., Harboth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Nature. 411:2001;494-498
9. Ono M., Handa K., Withers D.A., Hakomori S. Cancer Res. 59:1999;2335-2339
10. Ono M., Handa K., Sonnino S., Withers D.A., Nagai H., Hakomori S. Biochemistry. 40:2001;6414-6421
11. Satoh M., Ito A., Nojiri H., Handa K., Numahata K., Ohyama C., Saito S., Hoshi S., Hakomori S. Int. J. Oncol. 19:2001;723-731
12. Wittwer C.T., Herrmann M.G., Moss A.A., Rasmussen R.P. Biotechique. 22(1):1997;130-131. 134-138
13. Hakomori S. Kanfer J.N., Hakomori S. Sphingolipid Biochemistry. 1983;1-165 Plenum Press, New York
14. Nakamura K., Suzuki M., Taya C., Inagaki F., Yamakawa T., Suzuki A. J. Biochem. 110:1991;832-841
15. Kannagi R., Nudelman E.D., Levery S.B., Hakomori S. J. Biol. Chem. 257:1982;14865-14874
16. Magnani J.L., Smith D.F., Ginsburg V. Anal. Biochem. 109:1980;399-402
17. Miyake M., Ito M., Hitomi S., Ikeda S., Taki T., Kurata M., Hino A., Miyake N., Kannagi R. Cancer Res. 48:1988;6154-6160
18. Nores G.A., Dohi T., Taniguchi M., Hakomori S. J. Immunol. 139:1987;3171-3176
19. Watanabe R., Ohyama C., Aoki H., Takahashi T., Satoh M., Saito S., Hoshi S., Ishii A., Saito M., Arai Y. Cancer Res. 62:2002;3850-3854
20. Manfredi M.G., Lim S., Claffey K.P., Seyfried T.N. Cancer Res. 59:1999;5392-5397